MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 239 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $43,000 | +72.0% | 506 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | +47.1% | 506 | +7.7% | 0.00% | – |
| Q2 2019 | $17,000 | +30.8% | 470 | 0.0% | 0.00% | – |
| Q1 2019 | $13,000 | -96.7% | 470 | -97.7% | 0.00% | -100.0% |
| Q4 2018 | $390,000 | +3150.0% | 20,403 | +4962.8% | 0.00% | – |
| Q3 2018 | $12,000 | -20.0% | 403 | 0.0% | 0.00% | – |
| Q2 2018 | $15,000 | +15.4% | 403 | 0.0% | 0.00% | – |
| Q1 2018 | $13,000 | – | 403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
| Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
| BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
| HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
| Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
| Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
| Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
| Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
| DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
| Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |